Prostate Cancer Clinical Trial

Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening

Summary

The purpose of this study is to develop and evaluate a computer-based decision aid (DA) for use by men considering PSA screening for prostate cancer. Major medical organizations recommend that men discuss the risks and benefits of this test with their physician before making the decision. This educational, interactive DA will help them prepare for that discussion.

View Full Description

Full Description

Prostate cancer (CaP) is a formidable public health problem in the US and in industrialized countries worldwide. Methods for primary prevention of CaP are unknown. As a result, early detection has become a mainstay of cancer control efforts. However, there is considerable controversy regarding the efficacy of screening in reducing disease-specific mortality. In light of this uncertainty, major medical organizations, including the National Cancer Institute, currently recommend that men discuss the pros and cons of CaP screening and make individualized screening decisions with their health care providers. However, because of constraints on time during medical encounters, it is not always feasible for providers to engage in in-depth discussions regarding the complexities of this issue. Therefore, interventions to promote informed decision-making (IDM) outside of clinical settings are needed.

In this study, we propose to: (1) develop an interactive computer-based decision aid (DA) to promote IDM for CaP screening; and (2) conduct a randomized controlled worksite trial to evaluate the impact the DA intervention on employed men's ability to make informed decisions regarding CaP. This work is designed to be responsive to recent calls for IDM interventions in community settings among diverse populations. If successful, our findings could validate the effectiveness of DAs to promote IDM for CaP and serve as a model for widespread dissemination, thus improving quality of care.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Worksites employing at least 100 men in target age group (45-65 years old)

Exclusion Criteria:

Worksites with high turnover
Non-English speaking workers
Temporary or contract workers

Study is for people with:

Prostate Cancer

Phase:

Phase 3

Estimated Enrollment:

1120

Study ID:

NCT00207636

Recruitment Status:

Unknown status

Sponsor:

Centers for Disease Control and Prevention

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana-Farber Cancer Institute
Boston Massachusetts, 02115, United States More Info
Jennifer D Allen, PN MPH PhD
Contact
617-632-2269
[email protected]
Elizabeth A Harden, BA
Contact
617-632-2185
[email protected]
Jennifer D Allen, PN MPH ScD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 3

Estimated Enrollment:

1120

Study ID:

NCT00207636

Recruitment Status:

Unknown status

Sponsor:


Centers for Disease Control and Prevention

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider